Detalhe da pesquisa
1.
Pan-cancer whole-genome analyses of metastatic solid tumours.
Nature
; 575(7781): 210-216, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31645765
2.
The PRO-RCC study: a long-term PROspective Renal Cell Carcinoma cohort in the Netherlands, providing an infrastructure for 'Trial within Cohorts' study designs.
BMC Cancer
; 23(1): 648, 2023 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434119
3.
Cancer treatment and decision making in individuals with intellectual disabilities: a scoping literature review.
Lancet Oncol
; 23(4): e174-e183, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35358466
4.
Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Br J Cancer
; 126(6): 907-916, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912074
5.
Impact of DNA damage repair defects and aggressive variant features on response to carboplatin-based chemotherapy in metastatic castration-resistant prostate cancer.
Int J Cancer
; 148(2): 385-395, 2021 01 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32965028
6.
Screening and Stepped Care Targeting Psychological Distress in Patients With Metastatic Colorectal Cancer: The TES Cluster Randomized Trial.
J Natl Compr Canc Netw
; 17(8): 911-920, 2019 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31390590
7.
Four-year effects of exercise on fatigue and physical activity in patients with cancer.
BMC Med
; 16(1): 86, 2018 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29879968
8.
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Lancet Oncol
; 23(2): 198-201, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35114116
9.
Correction to: Impact of molecular tumour board discussion on targeted therapy allocation in advanced prostate cancer.
Br J Cancer
; 126(7): 1108, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35210590
10.
A randomised, phase II study of repeated rhenium-188-HEDP combined with docetaxel and prednisone versus docetaxel and prednisone alone in castration-resistant prostate cancer (CRPC) metastatic to bone; the Taxium II trial.
Eur J Nucl Med Mol Imaging
; 44(8): 1319-1327, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28421240
11.
Effects of an 18-week exercise programme started early during breast cancer treatment: a randomised controlled trial.
BMC Med
; 13: 121, 2015 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26050790
12.
Cemiplimab in locally advanced or metastatic cutaneous squamous cell carcinoma: prospective real-world data from the DRUG Access Protocol.
Lancet Reg Health Eur
; 39: 100875, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38464480
13.
How to create value with constrained budgets in oncological care? A narrative review.
Expert Rev Pharmacoecon Outcomes Res
; 23(9): 989-999, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37650221
14.
A Systematic Review and Multilevel Regression Analysis Reveals the Comorbidity Prevalence in Cancer.
Cancer Res
; 83(7): 1147-1157, 2023 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36779863
15.
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.
Cancers (Basel)
; 15(10)2023 May 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345149
16.
Cancer treatments touch a wide range of values that count for patients and other stakeholders: What are the implications for decision-making?
Cancer Med
; 12(5): 6105-6116, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36373590
17.
Pharmacokinetic boosting of olaparib: A randomised, cross-over study (PROACTIVE-study).
Eur J Cancer
; 194: 113346, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806255
18.
[Oncological treatment of patients with intellectual disability: too limited?] / Oncologische behandeling van patiënten met een verstandelijke beperking.
Ned Tijdschr Geneeskd
; 1662022 11 22.
Artigo
em Holandês
| MEDLINE | ID: mdl-36633030
19.
Consensus molecular subtype 4 (CMS4)-targeted therapy in primary colon cancer: A proof-of-concept study.
Front Oncol
; 12: 969855, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36147916
20.
Life-prolonging treatment restrictions and outcomes in patients with cancer and COVID-19: an update from the Dutch Oncology COVID-19 Consortium.
Eur J Cancer
; 160: 261-272, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34799210